Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992 Mar;83(3):135-9.

[Chronic Use of Glucomannan in the Dietary Treatment of Severe Obesity]

[Article in Italian]
Affiliations
  • PMID: 1313163
Clinical Trial

[Chronic Use of Glucomannan in the Dietary Treatment of Severe Obesity]

[Article in Italian]
P M Vita et al. Minerva Med. .

Abstract

Two groups of 25 severely obese patients underwent 3 months of hypocaloric diet therapy either alone or associated with a glucomannan-based fibrous diet supplement (approx. 4 g/die in 3 doses). The comparative analysis of the results obtained in both groups showed that the diet + glucomannan group had a more significant weight loss in relation to the fatty mass alone, an overall improvement in lipid status and carbohydrate tolerance, and a greater adherence to the diet in the absence of any relevant side effects. Due to the marked ability to satiate patients and the positive metabolic effects, glucomannan diet supplements have been found to be particularly efficacious and well tolerated even in the long-term treatment of severe obesity.

Similar articles

See all similar articles

Cited by 1 article

Feedback